LIVER/INTESTINAL METABOLISM ON BILE ACIDS/CHOLESTEROL
LIVER/INTESTINAL METABOLISM ON BILE ACIDS/CHOLESTEROL
批准号:
6380555
负责人:
PHILLIP B HYLEMON
金额:
$108.25万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-12-01 至 2002-09-29
中文摘要
胆固醇和胆汁酸在这一过程中
在“西方社会”的几个主要疾病中的作用,包括:
动脉硬化、胆固醇结石形成、胆汁淤积性肝
疾病和结肠癌发生。 此次更新的总体目标是
应用程序旨在更详细地了解胆汁的作用
酸在胆固醇和胆汁酸体内平衡的调节中起作用,
肝/肠生理学和胆固醇结石疾病。 的
总体目标将通过以下具体措施实现
目的:[1] a)确定蛋白激酶C的哪种亚型是
参与胆固醇7 α-羟化酶的调节; B)
确定蛋白激酶C亚型的活化机制
c)定义蛋白激酶C和胆汁酸响应性蛋白激酶C;
胆固醇7 α-羟化酶启动子的元件; d)
确定胆汁酸是否在体内激活蛋白激酶C亚型
肝脏和回肠(Vlahcevic,Stravitz,Heuman,Hylemon); [2] a)
定量胆汁盐对模型膜的吸附; B)开发
并验证了胆盐膜的一般定量模型
c)确定卵磷脂和胆固醇对吸附的影响;
胆盐对膜的毒性; d)确定
胆汁脂质成分对动物模型胆汁胆盐毒性的影响
胆盐诱导的肝损伤; e)确定蛋白激酶C
胆汁盐的激活是胆汁积聚的结果
膜表面的盐,可以通过定量预测
胆盐-膜吸附的建模(Heuman,Stravitz,
Valhcevic ; [3] a)选择性过表达胆固醇7 α-
羟化酶、甾醇27-羟化酶、胆固醇酯水解酶和
酰基辅酶A:胆固醇酰基转移酶(Hep G2和中国人
仓鼠卵巢细胞); B)评估每种酶在
维持细胞和全身胆固醇稳态,
体内重组腺病毒载体(仓鼠); c)研究
调节胆固醇酯水解酶和酰基辅酶A:胆固醇
原代大鼠肝细胞培养物和胆汁体内的酰基转移酶
酸、胆固醇和激素(潘达克、弗拉切维奇); [4] a)
完成一个大胆汁酸的克隆、测序和分析
来自肠真杆菌属VPI的可诱导操纵子(bai)
12708; B)确定每个基因产物编码的功能,
该操纵子在胆汁酸7 α/β-脱羟基化中起作用; c)分离,
表征和鉴定胆汁酸7 α-脱羟基细菌
来自胆固醇结石患者,其具有高(>30%)水平的
去氧胆酸,并确定这些患者是否被
独特的7种α-脱羟基细菌(Hylemon,Berr)。
英文摘要
Cholesterol and bile acids have been implicated in playing important
roles in several major diseases of "Western Society" including:
arteriosclerosis, cholesterol gallstone formation, cholestatic liver
disease and colon carcinogenesis. The overall goal of this renewal
application is aimed at a more detailed understanding of the role bile
acids play in the regulation of cholesterol and bile acid homeostasis,
liver/intestinal physiology, and cholesterol gallstone disease. The
overall goal will be accomplished through the following specific
aims: [1] a) Determine which isoform(s) of protein kinase C is
involved in the regulation of cholesterol 7 alpha-hydroxylase; b)
Determine the mechanism of activation of protein kinase C isoforms
by bile acids; c) Define protein kinase C and the bile acid responsive
element of the cholesterol 7 alpha-hydroxylase promoter; d)
Determine if bile acids activate protein kinase C isoforms in vivo in
liver and ileum (Vlahcevic, Stravitz, Heuman, Hylemon); [2] a)
Quantify adsorption of bile salts to model membranes; b) Develop
and validate a general quantitative model of bile salt-membrane
adsorption; c) Determine the effects of lecithin and cholesterol on
toxicity of bile salts toward membranes; d) Determine the effect of
biliary lipid composition on biliary bile salt toxicity in animal models
of bile salt induced liver injury; e) Determine if protein kinase C
activation by bile salts are consequences of the accumulation of bile
salts on the membrane surface that can be predicted by quantitative
modeling of bile salt-membrane adsorption (Heuman, Stravitz,
Valhcevic ; [3] a) Selective overexpression of cholesterol 7 alpha-
hydroxylase, sterol 27-hydroxylase, cholesterol ester hydrolase and
acyl CoA:cholesterol acyltransferase in vitro (Hep G2 and Chinese
hamster ovary cells); b) Assess the role each enzyme plays in
maintaining cellular and whole body cholesterol homeostasis using
recombinant adenovirus vectors in vivo (hamsters); c) Investigate the
regulation of cholesterol ester hydrolase and acyl CoA:cholesterol
acyltransferase in primary rat hepatocyte cultures and in vivo by bile
acids, cholesterol and hormones (Pandak, Vlahcevic); [4] a)
Complete the cloning, sequencing and analysis of a large bile acid
inducible operon (bai) from the intestinal Eubacterium sp. VPI
12708; b) Determine the function that each gene product encoded by
this operon plays inbile acid 7 alpha/beta-dehydroxylation; c) Isolate,
characterize and identify bile acid 7 alpha-dehydroxylating bacteria
from cholesterol gallstone patients having high (>30%) levels of
deoxycholic acid and determine if these patients are colonized by
unique 7 alpha-dehydroxylating bacterial species (Hylemon, Berr).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sphingolipids in alcoholic liver disease
-
批准号:10608594
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2023
-
负责人:PHILLIP B HYLEMON
-
依托单位:
LncRNA H19 in Cholestatic Liver Diseases
-
批准号:10202570
-
项目类别:
-
资助金额:$53.65万
-
财政年份:2018
-
负责人:PHILLIP B HYLEMON
-
依托单位:
LncRNA H19 in Cholestatic Liver Diseases
-
批准号:10909545
-
项目类别:
-
资助金额:$62.96万
-
财政年份:2018
-
负责人:PHILLIP B HYLEMON
-
依托单位:
LncRNA H19 in Cholestatic Liver Diseases
-
批准号:9750721
-
项目类别:
-
资助金额:$53.65万
-
财政年份:2018
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis
-
批准号:9024718
-
项目类别:
-
资助金额:$41.17万
-
财政年份:2015
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Bile Acids and Clostridium scindens Inhibit C. difficile: Role of Secreted Antibacterial Compounds
-
批准号:9233344
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Role of Bile Acids and Gut Bacteria in GI Diseases
-
批准号:8698288
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Role of Bile Acids and Gut Bacteria in GI Diseases
-
批准号:8536579
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Role of Bile Acids and Gut Bacteria in GI Diseases
-
批准号:8324091
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:7035831
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:6799002
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:6861103
-
项目类别:
-
资助金额:$33.23万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:7189897
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:7371133
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6369833
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6524254
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism
-
批准号:8824513
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6787328
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Bile Acid Activated Cell Signaling in the Liver and Nutrition
-
批准号:7629638
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6661859
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
海外基金